Javascript must be enabled to continue!
Prognostic Value of Electrophysiologic Investigations in Brugada Syndrome
View through CrossRef
Brugada Syndrome.
Introduction: The prognostic value of electrophysiologic investigations in individuals with Brugada syndrome is unclear. Previous studies failed to determine its value because of a limited number of patients or lack of events during follow‐up. We present data on the prognostic value of electrophysiologic studies in the largest cohort ever collected of patients with Brugada syndrome. Methods and Results: Two hundred fifty‐two individuals with an ECG diagnostic of Brugada syndrome were studied electrophysiologically. The diagnosis was made because of a classic ECG with a coved‐type ST segment elevation in precordial leads V1 to V3. Of the 252 individuals, 116 had previously developed spontaneous symptoms (syncope or aborted sudden cardiac death) and 136 were asymptomatic at the time of diagnosis. A sustained ventricular arrhythmia was induced in 130 patients (51%). Symptomatic patients were more frequently inducible (73%) than asymptomatic individuals (33%) (P = 0.0001). Fifty‐two individuals (21%) developed an arrhythmic event during a mean follow‐up of 34 ± 40 months. Inducibility was a powerful predictor of arrhythmic events during follow‐up both in symptomatic and asymptomatic individuals. Overall accuracy of programmed ventricular stimulation to predict outcome was 67%. Overall accuracy in asymptomatic individuals was 70.5%, with a 99% negative predictive value. Overall accuracy in symptomatic patients was 62%, with only a 4.5% false‐negative rate. No significant differences were found in the duration of the H‐V interval during sinus rhythm between symptomatic or asymptomatic individuals. However, the H‐V interval was significantly longer in the asymptomatic individuals who became symptomatic during follow‐up compared with those who did not develop symptoms (59 ± 8 msec vs 48 ± 11 msec, respectively; P = 0.04). Conclusion: Inducibility of sustained ventricular arrhythmias is a good predictor of outcome in Brugada syndrome. In asymptomatic individuals, a prolonged H‐V interval during sinus rhythm is associated with a higher risk of developing arrhythmic events during follow‐up. Symptomatic patients require protective treatment even when they are not inducible. Asymptomatic patients can be reassured if they are noninducible.
Title: Prognostic Value of Electrophysiologic Investigations in Brugada Syndrome
Description:
Brugada Syndrome.
Introduction: The prognostic value of electrophysiologic investigations in individuals with Brugada syndrome is unclear.
Previous studies failed to determine its value because of a limited number of patients or lack of events during follow‐up.
We present data on the prognostic value of electrophysiologic studies in the largest cohort ever collected of patients with Brugada syndrome.
Methods and Results: Two hundred fifty‐two individuals with an ECG diagnostic of Brugada syndrome were studied electrophysiologically.
The diagnosis was made because of a classic ECG with a coved‐type ST segment elevation in precordial leads V1 to V3.
Of the 252 individuals, 116 had previously developed spontaneous symptoms (syncope or aborted sudden cardiac death) and 136 were asymptomatic at the time of diagnosis.
A sustained ventricular arrhythmia was induced in 130 patients (51%).
Symptomatic patients were more frequently inducible (73%) than asymptomatic individuals (33%) (P = 0.
0001).
Fifty‐two individuals (21%) developed an arrhythmic event during a mean follow‐up of 34 ± 40 months.
Inducibility was a powerful predictor of arrhythmic events during follow‐up both in symptomatic and asymptomatic individuals.
Overall accuracy of programmed ventricular stimulation to predict outcome was 67%.
Overall accuracy in asymptomatic individuals was 70.
5%, with a 99% negative predictive value.
Overall accuracy in symptomatic patients was 62%, with only a 4.
5% false‐negative rate.
No significant differences were found in the duration of the H‐V interval during sinus rhythm between symptomatic or asymptomatic individuals.
However, the H‐V interval was significantly longer in the asymptomatic individuals who became symptomatic during follow‐up compared with those who did not develop symptoms (59 ± 8 msec vs 48 ± 11 msec, respectively; P = 0.
04).
Conclusion: Inducibility of sustained ventricular arrhythmias is a good predictor of outcome in Brugada syndrome.
In asymptomatic individuals, a prolonged H‐V interval during sinus rhythm is associated with a higher risk of developing arrhythmic events during follow‐up.
Symptomatic patients require protective treatment even when they are not inducible.
Asymptomatic patients can be reassured if they are noninducible.
Related Results
Abstract 4138514: From Treatment to Trigger: A Case of Atomoxetine-Induced Brugada Pattern
Abstract 4138514: From Treatment to Trigger: A Case of Atomoxetine-Induced Brugada Pattern
Introduction:
Brugada syndrome is an inherited cardiac disorder characterized by specific ECG patterns, notably the coved-type ST-segment elevation in the right precord...
Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic?
Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic?
Brugada syndrome is a rare inherited arrhythmogenic disease leading to ventricular fibrillation and high risk of sudden death. In 1998, this syndrome was linked with a genetic vari...
Electrocardiographic Effects of Propofol versus Etomidate in Patients with Brugada Syndrome
Electrocardiographic Effects of Propofol versus Etomidate in Patients with Brugada Syndrome
Abstract
Background
Brugada Syndrome is an inherited arrhythmogenic disease, characterized by the typical coved type ST-segment elevation in the ...
Genetic and Molecular Mechanisms in Brugada Syndrome
Genetic and Molecular Mechanisms in Brugada Syndrome
Brugada syndrome is a rare hereditary arrhythmia disorder characterized by a distinctive electrocardiogram pattern and an elevated risk of ventricular arrhythmias and sudden cardia...
Brugada Syndrome and Pregnancy: Highlights on Antenatal and Prenatal Management
Brugada Syndrome and Pregnancy: Highlights on Antenatal and Prenatal Management
Introduction. Brugada syndrome is characterized by a disruption of heart’s normal rhythm. It is an autosomal dominant disease due to a mutation of SNC5A gene. Its prevalence is low...
Brugada Syndrome
Brugada Syndrome
AbstractBrugada syndrome (BrS) is characterised by right bundle branch block and persistent ST‐segment elevation in right precordial leads. It is responsible for 4–12% of total sud...
Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest
Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest
Background—
Patients with Brugada syndrome who were resuscitated from an episode of ventricular fibrillation are at high risk for recurrent sudden death. T...
Brugada Syndrome and Anesthesia: A Systematic Review
Brugada Syndrome and Anesthesia: A Systematic Review
Brugada Syndrome is an inherited disorder causing specific changes on
electrocardiogram (ECG) pattern of right bundle branch block and
persistent ST elevation in right precordial l...

